Dwayne Allen - 21 Jul 2026 Form 4 Insider Report for CROSS COUNTRY HEALTHCARE INC (CCRN)

Reporting relationship: Director
Issuer ticker: CCRN
Reported as of: 21 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 21 Jul 2026, 16:08:48 UTC
Prior SEC filing: 28 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Dwayne Allen

Key filing fact

Dwayne Allen filed Form 4 for CROSS COUNTRY HEALTHCARE INC (CCRN) on 21 Jul 2026.

Key facts

This page summarizes Dwayne Allen's Form 4 filing for CROSS COUNTRY HEALTHCARE INC (CCRN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 21 Jul 2026, 16:08.

Change

Previous filing in this sequence was filed on 28 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001857647 Primary reporting owner

Allen Dwayne

Relationship: Director
Address: C/O CROSS COUNTRY HEALTHCARE, INC., 5201 CONGRESS AVENUE, SUITE 160, BOCA RATON
Signature: /s/ Dwayne Allen
Signature date: 21 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CCRN transaction

Common Stock

Disposed to Issuer

Transaction value
Shares: -31,289
Change %: -100%
Price: $13.25^*
Shares after: 0
Date: 21 Jul 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Dwayne Allen is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 2 footnotes

Footnote F1

Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 6, 2026, by and among Cross Country Healthcare, Inc., a Delaware corporation (the "Issuer"), KL Criss Cross Intermediate, LLC, a Delaware limited liability company ("Parent"), and KL Criss Cross Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent, (continued in footnote 2)

Footnote F2

at the effective time of the Merger (the "Effective Time"), each (i) share of Issuer common stock ("Common Stock") issued and outstanding immediately prior to the Effective Time was automatically converted into the right to receive $13.25 in cash (the "Merger Consideration") and (ii) each restricted stock award with respect to shares of Common Stock outstanding immediately prior to the Effective Time was fully vested, cancelled and converted into the right to receive an amount in cash equal to the number of shares of Common Stock subject to such award immediately prior to the Effective Time multiplied by the Merger Consideration.